OR WAIT null SECS
June 10, 2022
Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.
The expansion at Seqirus’ Holly Springs, N.C., manufacturing facility will support the formulation and fill/finish of influenza vaccines.
May 26, 2022
Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.
AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.
May 16, 2022
Flexible and efficient methods are needed for biopharmaceutical manufacturing.
The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.
May 03, 2022
Resolving operational bottlenecks makes mAb manufacturing more efficient.
April 06, 2022
Standardization is needed in CAR-T cell therapy development due to its inherent complexity.
March 02, 2022
Capacity concerns and regulatory compliance considerations will drive the decision about outsourcing the manufacture of clinical trial materials.
February 21, 2022
Recipharm has strengthened its biologics manufacturing capabilities with the acquisition of both Vibalogics and Arranta Bio.
